Latest posts tagged with #TargetedTherapy on Bluesky
🔷 However, the combination did not improve overall survival (OS) (15.0 vs 17.9 months; HR 1.15) and was associated with higher grade 3–4 adverse events (66.9% vs 38.3%).
🔗 Read more: bit.ly/ONCOnews13-M...
#ONCOnews #OncoAlert #OncEd #Oncology #CancerResearch #Immunotherapy #TargetedTherapy
China impulsa la innovación en oncología.
📊 Descubre en este póster 5 medicamentos innovadores para el cáncer de mama.
#CáncerDeMama #Dalpiciclib #Pyrotinib #Chidamide #Envafolimab #DisitamabVedotin #HER2 #HER2Positive #TargetedTherapy #ADC #TerapiasInnovadoras #DengYueMedicinasEnHongKong
in4u.org/china-russia... Russia and China report early success using a Chinese targeted therapy for rare head‑and‑neck cancers. Their partnership now expands into CAR‑T, TIL, and mRNA research, with a new mirror lab planned in Moscow.
#ChinaRussiaOncology #CancerResearch #TargetedTherapy
🌍 Cada año se diagnostican ~20 millones de nuevos casos de cáncer en el mundo.
Los avances en detección temprana, terapias dirigidas e inmunoterapia están mejorando el tratamiento.
💬 ¿Qué medicamento contra el cáncer quieres que expliquemos después?
#immunotherapy #targetedtherapy #DengYueMed
🔬🌍 Revolutionizing healthcare with nano-enabled smart drug delivery! Our review explores the latest advances in targeted therapy and theranostics within the One Health framework. 🦟🌟
📚Read more: link.springer.com/article/10.1... 🔗
#Nanomedicine #OneHealth #TargetedTherapy
Stories like this highlight the potential of targeted therapies to change outcomes and spare patients from more invasive treatments. The future of oncology is becoming increasingly personalized.
#TargetedTherapy #CancerResearch #TCSC
🔷 The LITESPARK-022 Phase 3 data suggests added benefit from combining PD-1 blockade with HIF-2α inhibition in the post-nephrectomy setting.
🔗 Read more: bit.ly/ONCOnews02-M...
#ONCOnews #OncoAlert #OncEd #Oncology #CancerResearch #Immunotherapy #TargetedTherapy #RenalCellCarcinoma #KidneyCancer
Zongertinib Receives FDA Accelerated Approval in HER2-Mutant NSCLC
oncodaily.com/oncolibrary/...
#OncoDaily #Oncology #Cancer #Health #Medicine #NSCLC #MedEd #MedOnc #MedNews #LungCancer #HER2 #TargetedTherapy #FDAApproval
#Review
#TGF-β in #tumor development and progression: mechanisms and therapeutics doi.org/10.1186/s435...
Authored by researchers from #SoochowUniversity
#signaling #TME #Metastasis #immunity #TargetedTherapy
5
A comprehensive overview of signaling pathways in colorectal cancer, spanning pathogenesis to targeted therapy.
A roadmap for translational research.
doi.org/10.1038/s413...
#ColorectalCancer #SignalTransduction #CancerPathogenesis #TargetedTherapy #OncologyReview
Colon cancer research is advancing across clinical trials, tumor biology, metabolism, immunity and single-cell genomics.
Explore the latest discoveries from Signal Transduction and Targeted Therapy:
www.nature.com/sigtrans/
#ColonCancer #ColorectalCancer #SignalTransduction #TargetedTherapy
New review - The treatment landscape for advanced gastric/GEJ adenocarcinoma is rapidly evolving. Upfront ICIs, targeted agents, and biomarker‑guided strategies are reshaping first‑line, maintenance, and sequential therapy.
🔗 buff.ly/22B0Oz0
#GastricCancer #GEJ #Immunotherapy #TargetedTherapy
Support free patient education — donate today. 💙
#LungCancer #Biomarkers #TargetedTherapy
Support free patient education — donate today. 💙
#LungCancer #TargetedTherapy #PrecisionMedicine
Synapse: Your Connection to our MSK Authors
Meet: Fernando Costa Santini
Research Focus: Medicine; Assistant Attending
A phase II study of cabozantinib in patients with MET-altered lung cancers
synapse.mskcc.org/synapse/work...
#LungCancer #METAltered
#TargetedTherapy #PrecisionOncology
Register:
give.cancergrace.org/event/lung-c...
Support free patient education — donate today. 💙
#LungCancer #NSCLC #TargetedTherapy
🎗️ Melanoma — Recent Research
• Long-term survival improves with neoadjuvant checkpoint blockade
• Targeted therapy benefits linked to mutation burden
• CRISPR screens and toxicity insights refine immunotherapy strategy
pir.sh/rk915wQanp
#Melanoma #Immunotherapy #TargetedTherapy #CancerResearch
Lung cancer in ‘never-smokers’ draws new focus — and questions
statnews.com/2026/02/11/l...
#LungCancer #NeverSmokers #LungCancerAwareness #CancerResearch #ThoracicOncology#PrecisionMedicine #TargetedTherapy #EnvironmentalHealth #AirPollution #PublicHealth #CancerPrevention #OncologyResearch
Doctors use regorafenib tablets to treat advanced cancers because the drug delivers targeted treatment which provides patients with hope. Doctors often recommend regorafenib tablets 40 mg, as part of treatment plans for colorectal cancer, gastrointestinal stromal tumors, and liver cancer. The treatment value of regorafenib tablets 40 mg, derives from their capacity to inhibit various protein kinases which drive tumor development and vascularization. Patients need to follow dosage instructions with precision while they need to consult healthcare professionals about potential side effects before they begin regorafenib tablets 40 mg therapy.When researching options, many patients compare the regorafenib tablets 40 mg and review the regorafenib 40 mg tablet price to plan their treatment budget. Oddway international provides trustworthy information to assist patients who require authentic oncology medications and global supply chain assistance.
Regorafenib 40 mg Tablets Price, Side Effects & Generic - Oddway
www.oddwayinternational.com/regorafenib-...
#RegorafenibTablets40mg #RegorafenibTreatment #CancerTherapy #TargetedTherapy
The medical community uses Imatinib Tablets IP 400 mg as a standard treatment for targeted cancer therapy. The treatment of chronic myeloid leukemia (CML) and gastrointestinal stromal tumors (GIST) uses Imatinib Tablets IP 400 mg because they block specific proteins which drive uncontrolled cell development. How Imatinib Tablets IP 400 mg Help Manage Chronic Myeloid Leukemia Patients using Imatinib Tablets should always follow medical guidance to ensure safe and effective results. Quickbloging serves as an informational platform which spreads knowledge about new medical treatments and their advantages. Oddway international provides multiple trustworthy sources which enable healthcare professionals and patients to access quality medicines that they can find throughout the world.
How Imatinib Tablets IP 400 mg Help Manage Chronic Myeloid Leukemia
quickbloging.com/how-imatinib...
#ImatinibTabletsIP400m #ImatinibTablets #CancerTreatment
#TargetedTherapy
Doctors use Regorafenib 40 mg as an oral targeted therapy which treats specific advanced cancers that include colorectal cancer and gastrointestinal stromal tumors. The medication functions by blocking specific proteins which enable cancerous tumors to grow and new blood vessels to develop through their formation. Doctors may recommend Regorafenib 40 mg when other treatments have not delivered the expected results. Patients should follow medical guidelines during their regorafenib tablet 40 mg treatment because this practice will enable them to achieve optimal treatment results while managing possible side effects.The patients need to consult their healthcare provider about treatment dosage requirements and safety precautions before starting regorafenib 40 mg tablet treatment and they should also inquire about regorafenib 40 mg tablet pricing information. Patients throughout the world can access Regorafenib 40 mg through reliable suppliers such as oddway international which provides access to the medication with quality assurance and complete support.
Regorafenib 40 mg Tablets Price, Side Effects & Generic - Oddway
www.oddwayinternational.com/regorafenib-...
#Regorafenib40mg #RegorafenibTablets40mg
#Regorafenib40mgTabletPrice #TargetedTherapy
🔷 The randomized study is designed to assess efficacy and safety versus placebo, with progression-free survival (PFS) as the primary endpoint.
🔗 Read more: bit.ly/ONCOnews10Fe...
#ONCOnews #OncoAlert #OncEd #Glioma #Phase3Trial #ClinicalTrials #Oncology #NeuroOncology #TargetedTherapy
This approach turns tumors’ own biology against them, pointing toward gentler therapies with fewer side effects. #TargetedTherapy #TCSC
Biomarker analysis of circulating tumor DNA in clinical stage III melanoma patients treated with neoadjuvant immunotherapy combined with targeted therapy
@tamedoncol.bsky.social
@journals.sagepub.com
journals.sagepub.com/doi/10.1177/...
#skincancer #PET #targetedtherapy #oncology #openaccess
Targeted therapy ≠ chemotherapy.
It works by attacking specific genetic mutations in lung cancer cells,
like EGFR, ALK, ROS1, MET, and HER2.
Right target, better results.
Gene testing comes first.
📩 info@dengyuemed.com
🔗https://dengyuemed.com
#LungCancer #TargetedTherapy
Review: Histologic transformation is a key mechanism of resistance in driver‑positive NSCLC, leading to aggressive SCLC, squamous, or neuroendocrine phenotypes.⬇️ summarize mechanisms and treatment options.
🔗 buff.ly/jJq7xOQ
#NSCLC #LungCancer #Oncology #TargetedTherapy
A new blood test developed by The Institute of Cancer Research predicts how well patients with advanced breast cancer will respond to targeted therapies.
healthcaretoday.com/article/brea...
#Healthcare #BreastCancer #TargetedTherapy #PatientSafety
Knowledge empowers better conversations and informed decisions. 💙
🔗 Watch now: www.youtube.com/watch?v=rBX4...
#LungCancer #NSCLC #CancerEducation #TargetedTherapy #OncologyUpdates #PatientEducation
Advances in molecular pathology and therapy of non-small cell lung cancer
An in-depth overview of NSCLC molecular pathology, oncogenic drivers, targeted therapies, and resistance mechanisms.
doi.org/10.1038/s413...
#NSCLC #MolecularPathology #TargetedTherapy #PrecisionOncology
Advances in molecular pathology and therapy of non-small cell lung cancer
An in-depth overview of NSCLC molecular pathology, oncogenic drivers, targeted therapies, and resistance mechanisms.
doi.org/10.1038/s413...
#NSCLC #MolecularPathology #TargetedTherapy #PrecisionOncology
